A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States

Hisham Abdel Azim; Chelsea Balian; Priti Tewari; Ruth Santizo; Neena Kapoor; Kris M. Mahadeo

doi:10.1002/pbc.25355

A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States

Hisham Abdel Azim, Chelsea Balian, Priti Tewari, Ruth Santizo, Neena Kapoor, Kris M. Mahadeo

Pediatrics

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44-68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required. Pediatr Blood Cancer 2015;62:731-735.

Original language	English (US)
Pages (from-to)	731-735
Number of pages	5
Journal	Pediatric Blood and Cancer
Volume	62
Issue number	4
DOIs	https://doi.org/10.1002/pbc.25355
State	Published - Apr 1 2015

Keywords

BMT
FACT
Infectious diseases
Pediatrics
Voriconazole

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pbc.25355

Cite this

@article{1a1c12481b804ad99ba8b89745114366,

title = "A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States",

abstract = "We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44-68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required. Pediatr Blood Cancer 2015;62:731-735.",

keywords = "BMT, FACT, Infectious diseases, Pediatrics, Voriconazole",

author = "Azim, {Hisham Abdel} and Chelsea Balian and Priti Tewari and Ruth Santizo and Neena Kapoor and Mahadeo, {Kris M.}",

note = "Publisher Copyright: {\textcopyright} 2015 Wiley Periodicals, Inc.",

year = "2015",

month = apr,

day = "1",

doi = "10.1002/pbc.25355",

language = "English (US)",

volume = "62",

pages = "731--735",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States

AU - Azim, Hisham Abdel

AU - Balian, Chelsea

AU - Tewari, Priti

AU - Santizo, Ruth

AU - Kapoor, Neena

AU - Mahadeo, Kris M.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44-68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required. Pediatr Blood Cancer 2015;62:731-735.

AB - We assessed clinical practice standards for infectious complications among pediatric blood and marrow transplant (PBMT) recipients. An anonymous online survey was sent to all 64 pediatric program directors (PD) of PBMT centers in the United States, which are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). The overall response rate was 56% (CI: 44-68%); variations in clinical practices were noted regarding (i) surveillance for late onset cytomegalovirus (CMV) infection and (ii) pharmacokinetic/therapeutic drug monitoring of antimicrobials. Prospective studies among PBMT recipients to address infectious complications among this population and variations in clinical practice may be required. Pediatr Blood Cancer 2015;62:731-735.

KW - BMT

KW - FACT

KW - Infectious diseases

KW - Pediatrics

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=84923198007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923198007&partnerID=8YFLogxK

U2 - 10.1002/pbc.25355

DO - 10.1002/pbc.25355

M3 - Article

C2 - 25557155

AN - SCOPUS:84923198007

SN - 1545-5009

VL - 62

SP - 731

EP - 735

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 4

ER -

A survey of infectious disease clinical practices among pediatric blood and marrow transplant programs in the United States

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this